Manulife (Manufacturers Life Insurance)
PVLA

Manulife (Manufacturers Life Insurance)’s Palvella Therapeutics PVLA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23M Buy
17,907
+15,637
+689% +$1.63M ﹤0.01% 1453
2025
Q4 		$238K Buy
+2,270
New +$194K ﹤0.01% 2443
2021
Q1 		– Sell
-475
Closed -$95K – 3133
2020
Q4 		$95K Buy
475
+60
+14% +$12.5K ﹤0.01% 2958
2020
Q3 		$69K Hold
415
– – ﹤0.01% 2869
2020
Q2 		$106K Buy
415
+2
+0.5% +$468 ﹤0.01% 2741
2020
Q1 		$75K Buy
413
+27
+7% +$6.8K ﹤0.01% 2659
2019
Q4 		$112K Sell
386
-16
-4% -$4.44K ﹤0.01% 2771
2019
Q3 		$116K Sell
402
-2
-0.5% -$774 ﹤0.01% 2794
2019
Q2 		$152K Sell
404
-91
-18% -$27.1K ﹤0.01% 2775
2019
Q1 		$133K Buy
495
+52
+12% +$12.4K ﹤0.01% 2536
2018
Q4 		$95K Sell
443
-16
-3% -$4.96K ﹤0.01% 2446
2018
Q3 		$206K Sell
459
-67
-13% -$29.1K ﹤0.01% 2754
2018
Q2 		$214K Buy
526
+141
+37% +$67.1K ﹤0.01% 3079
2018
Q1 		$211K Buy
385
+19
+5% +$11.8K ﹤0.01% 2983
2017
Q4 		$221K Sell
366
-18
-5% -$8.37K ﹤0.01% 2925
2017
Q3 		$177K Sell
384
-13
-3% -$5.55K ﹤0.01% 3072
2017
Q2 		$161K Buy
397
+364
+1,103% +$106K ﹤0.01% 3178
2017
Q1 		$7K Hold
33
– – ﹤0.01% 3727
2016
Q4 		$4K Hold
33
– – ﹤0.01% 3995
2016
Q3 		$5K Hold
33
– – ﹤0.01% 3894
2016
Q2 		$4K Hold
33
– – ﹤0.01% 3878
2016
Q1 		$5K Buy
+33
New +$4.64K ﹤0.01% 3796

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PVLA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Palvella Therapeutics (PVLA) stake by 689% in Q1 2026, buying an estimated $1.63M and bringing the position to 17,907 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

Manulife (Manufacturers Life Insurance) first reported a position in PVLA in Q1 2016 and has held it in 22 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 17,907 shares of Palvella Therapeutics worth $2.23M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 15,637 Palvella Therapeutics shares in Q1 2026, an estimated $1.63M.
  • Palvella Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1453 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Palvella Therapeutics in Q1 2016 and has held it in 22 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.